Pancreatic Cancer Research

ResearcherDuke UniversityActive in the last 2 years

David M. Virshup

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6976-850X; OpenAlex author ID A5028126403. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 3

  1. EPHA2 and WNT reciprocally regulate MAPK-dependent gene expression in a pancreatic cancer model. Co-author DOI 10.1172/jci.insight.202630↗
  2. Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer. Last author DOI 10.1172/jci191370↗
  3. A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models. Last author DOI 10.1172/jci156305↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Babita Madan · 2 shared papers, 2022–2026 · strength 0.54
  2. Zheng Zhong · 2 shared papers, 2022–2026 · strength 0.49
  3. Roger J. Daly · 1 shared paper, 2026 · strength 0.33
  4. Shawn R. Wadia · 1 shared paper, 2026 · strength 0.33
  5. Clint A. Stalnecker · 1 shared paper, 2026 · strength 0.29
  6. Channing J. Der · 1 shared paper, 2026 · strength 0.29

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.